<DOC>
	<DOCNO>NCT01208467</DOCNO>
	<brief_summary>This research study study prognostic biomarkers tissue sample patient endometrial cancer . Studying sample tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer .</brief_summary>
	<brief_title>Prognostic Biomarkers Patients With Endometrial Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To validate clinicopathologic association prognostic significance ATR mutation endometrioid endometrial cancer case defective DNA mismatch repair . OUTLINE : This multicenter study . DNA extract previously collect tumor sample analyze validate clinicopathologic association prognostic significance ATR mutation .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<criteria>Women eligible evaluable GOG0210 molecular stag protocol woman endometrial cancer Women register unrestricted enrollment period ( 9/23/07 ) automatically qualify Women register restricted enrollment period ( 9/23/07 ) consider needed Women histologically confirm endometrioid endometrial adenocarcinoma regardless stage grade Women defective DNA mismatch repair microsatellite instability positive ( MSI+ MSIlow ) Women consent allow specimen clinical data use future cancer research Women sufficient highquality genomic DNA tumor available mutation analysis ATR</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>